A new fragment design platform!
We are thrilled to announce our collaboration between Enamine and ChemPass to advance fragment-based drug discovery. ChemPass will apply its Universal Fragment Library (UFL) Design Platform to create target-specific fragment libraries, while Enamine will contribute with efficient synthesis and screening. This collaborative initiative will accelerate hit finding and the hit-to-lead process for our customers that seek to shorten their early discovery cycles.
UFL
A Universal Fragment Library designed using vast protein-ligand binding knowledge to enhance hit discovery.
Enhancement with UFrag™
Optimize your fragment libraries for better hit rates, binding coverage, and efficient screening.
Fragment Screening Service
A streamlined screening process combining fragment screening, computational tools, and vast chemical space.
